RCSB PDB - CIA Ligand Summary Page (original) (raw)

6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE

Find entries where: CIA

is present as a standalone ligand in 2 entries

Chemical Component Summary
Name 6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE
Synonyms TADALAFIL; CIALIS
Identifiers n/a
Formula C22 H19 N3 O4
Molecular Weight 389.404
Type NON-POLYMER
Isomeric SMILES CN1CC(=O)N2[C@@H](C1=O)Cc3c4ccccc4[nH]c3[C@H]2c5ccc6c(c5)OCO6
InChI InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1
InChIKey WOXKDUGGOYFFRN-IIBYNOLFSA-N
Chemical Details
Formal Charge 0
Atom Count 48
Chiral Atom Count 2
Bond Count 53
Aromatic Bond Count 16

Drug Info: DrugBank

DrugBank ID DB00820
Name Tadalafil
Groups investigationalapproved
Description Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]
Synonyms (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dioneTadalafilTadalafilo(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
Brand Names TadliqTadalafilAg-tadalafilMar-tadalafilRiva-tadalafilMint-tadalafilCialisAch-tadalafilDom-tadalafilBio-tadalafilOpsynviPriva-tadalafilTadalfilTadalafil LillyTadalafil MylanJamp-tadalafilM-tadalafilRan-tadalafilApo-tadalafil PahApo-tadalafilAct TadalafilTalmancoAlyqEntadfiPrz-tadalafilPMS-tadalafilAuro-tadalafilTeva-tadalafilAdcircaMylan-tadalafilNra-tadalafilIpg-tadalafil
Indication Tadalafil is indicated for the treatment of erectile dysfunction (ED) and either alone or in combination with [finasteride] for the treatment of benign prostatic hypertrophy (BPH).[L39095,L39439] It is also indicated for the treatment of pulmonary arterial hypertension (PAH) both alone and in combination with [macitentan] or other endothelin-1 antagonists.[L39100,L39105]
Categories 5-alpha Reductase InhibitorsAntihypertensive AgentsAntihypertensives for Pulmonary Arterial HypertensionCarbolinesCardiovascular AgentsCytochrome P-450 CYP3A SubstratesCytochrome P-450 CYP3A4 SubstratesCytochrome P-450 CYP3A5 SubstratesCytochrome P-450 SubstratesDrugs that are Mainly Renally ExcretedDrugs Used in Benign Prostatic HypertrophyDrugs Used in Erectile DysfunctionEnzyme InhibitorsGenito Urinary System and Sex HormonesGenitourinary AgentsHeterocyclic Compounds, Fused-RingIndole AlkaloidsIndolesPhosphodiesterase 5 InhibitorsPhosphodiesterase InhibitorsPyridinesUrological AgentsUrologicalsVasodilating Agents
ATC-Code G04BE08C02KX52G04CB51G04CA54C02KX54
CAS number 171596-29-5

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Resource Name Reference
Pharos CHEMBL779
PubChem 110635
ChEMBL CHEMBL779
ChEBI CHEBI:71940
CCDC/CSD IQUMAI, LASZUC, LATBAL, LATBEP, KAJKUE, KAJKOY, IQUMAI01, CIKPIY, VAGMID
COD 7207636